Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Vitamin C Proves Toxic to Tumors

By Biotechdaily staff writers
Posted on 11 Oct 2005
A recent study by researchers concluded that tumor-toxic levels of vitamin C could be achieved by administering the vitamin intravenously (IV).

Investigators at the U.S. More...
National Institutes of Health (NIH, Bethesda, MD, USA) recently confirmed that vitamin C is selectively toxic to tumor cells. The study was published in the September 12, 2005, issue of the journal Proceedings of the [U.S.] National Academy of Sciences. "These findings give plausibility to iv ascorbic acid in cancer treatment..,” reported the authors in the article.

"It is gratifying to have our research on vitamin C and cancer confirmed by scientists at the prestigious National Institutes of Health,” stated Neil Riordan, Ph.D., from the Bio-Communications Research Institute (BCRI, Wichita, KS, USA). BCRI scientists were the first to describe the pharmacokinetics of high doses of vitamin C. Their study was published in the British Journal of Cancer in 2001.

Since 1990, BCRI has published 20 articles on the study of vitamin C and cancer, and funded the first clinical phase I trial of IV vitamin C in patients with advanced gastrointestinal cancer. Findings of that trial will be forthcoming.






Related Links:
Bio-Communications Research Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Prefilled Tubes
Prefilled 5.0ml Tubes
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.